In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)
- PMID: 2817862
- PMCID: PMC172720
- DOI: 10.1128/AAC.33.9.1634
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)
Abstract
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
